在患有C3型血球病变的儿童中,用佩格西塔科普兰抑制补充剂的有效性

Maria Cristina Mancuso1, Massimo Cugno2, Samantha Griffini3

  • 1Center for HUS Prevention, Control and Management at the Pediatric Nephrology, Dialysis and Transplantation Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

概括

标签外的佩格塞塔科普兰治疗改善了儿科C3球球病 (C3G) 患者的功能. 这项研究显示了对C3G的补充向治疗有前途的结果.